317 related articles for article (PubMed ID: 33610611)
1. Vipers of Major clinical relevance in Europe: Taxonomy, venom composition, toxicology and clinical management of human bites.
Di Nicola MR; Pontara A; Kass GEN; Kramer NI; Avella I; Pampena R; Mercuri SR; Dorne JLCM; Paolino G
Toxicology; 2021 Apr; 453():152724. PubMed ID: 33610611
[TBL] [Abstract][Full Text] [Related]
2. Venomics of Vipera berus berus to explain differences in pathology elicited by Vipera ammodytes ammodytes envenomation: Therapeutic implications.
Latinović Z; Leonardi A; Šribar J; Sajevic T; Žužek MC; Frangež R; Halassy B; Trampuš-Bakija A; Pungerčar J; Križaj I
J Proteomics; 2016 Sep; 146():34-47. PubMed ID: 27327134
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of
Kurtović T; Lang Balija M; Brvar M; Dobaja Borak M; Mateljak Lukačević S; Halassy B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33805701
[TBL] [Abstract][Full Text] [Related]
4. Antivenom for European Vipera species envenoming.
Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
[TBL] [Abstract][Full Text] [Related]
5. Venom-Induced Blood Disturbances by Palearctic Viperid Snakes, and Their Relative Neutralization by Antivenoms and Enzyme-Inhibitors.
Chowdhury A; Zdenek CN; Lewin MR; Carter R; Jagar T; Ostanek E; Harjen H; Aldridge M; Soria R; Haw G; Fry BG
Front Immunol; 2021; 12():688802. PubMed ID: 34177943
[TBL] [Abstract][Full Text] [Related]
6. Venomous snakebites.
Adukauskienė D; Varanauskienė E; Adukauskaitė A
Medicina (Kaunas); 2011; 47(8):461-7. PubMed ID: 22123554
[TBL] [Abstract][Full Text] [Related]
7. Snakebites in Hungary--epidemiological and clinical aspects over the past 36 years.
Malina T; Krecsák L; Korsós Z; Takács Z
Toxicon; 2008 May; 51(6):943-51. PubMed ID: 18241904
[TBL] [Abstract][Full Text] [Related]
8. Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation.
Brvar M; Kurtović T; Grenc D; Lang Balija M; Križaj I; Halassy B
Clin Toxicol (Phila); 2017 Apr; 55(4):241-248. PubMed ID: 28092984
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Assessment of a New Polyvalent Antivenom (Inoserp Europe) against Several Species of the Subfamily Viperinae.
García-Arredondo A; Martínez M; Calderón A; Saldívar A; Soria R
Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30841582
[TBL] [Abstract][Full Text] [Related]
10. Intravenous
Kurtović T; Karabuva S; Grenc D; Dobaja Borak M; Križaj I; Lukšić B; Halassy B; Brvar M
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919927
[No Abstract] [Full Text] [Related]
11. Viper envenomation in Central and Southeastern Europe: a multicentre study.
Dobaja Borak M; Babić Ž; Caganova B; Grenc D; Karabuva S; Kolpach Z; Krakowiak A; Kolesnikova V; Lukšić B; Pap C; Puljiz I; Piekarska-Wijatkowska A; Radenkova-Saeva J; Vučinić S; Zacharov S; Eddleston M; Brvar M
Clin Toxicol (Phila); 2023 Sep; 61(9):656-664. PubMed ID: 37988116
[TBL] [Abstract][Full Text] [Related]
12. Interpopulational variation and ontogenetic shift in the venom composition of Lataste's viper (Vipera latastei, Boscá 1878) from northern Portugal.
Avella I; Calvete JJ; Sanz L; Wüster W; Licata F; Quesada-Bernat S; Rodríguez Y; Martínez-Freiría F
J Proteomics; 2022 Jul; 263():104613. PubMed ID: 35589061
[TBL] [Abstract][Full Text] [Related]
13. Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb.
Casewell NR; Al-Abdulla I; Smith D; Coxon R; Landon J
Toxins (Basel); 2014 Aug; 6(8):2471-82. PubMed ID: 25153254
[TBL] [Abstract][Full Text] [Related]
14. Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms.
Zanetti G; Duregotti E; Locatelli CA; Giampreti A; Lonati D; Rossetto O; Pirazzini M
Sci Rep; 2018 Jun; 8(1):9818. PubMed ID: 29959358
[TBL] [Abstract][Full Text] [Related]
15. A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation.
Kurtović T; Brvar M; Grenc D; Lang Balija M; Križaj I; Halassy B
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27548220
[TBL] [Abstract][Full Text] [Related]
16. Biological Activities and Proteomic Profile of the Venom of
Lang Balija M; Leonardi A; Brgles M; Sviben D; Kurtović T; Halassy B; Križaj I
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188060
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment.
Czajka U; Wiatrzyk A; Lutyńska A
Przegl Epidemiol; 2013; 67(4):641-6, 729-33. PubMed ID: 24741911
[TBL] [Abstract][Full Text] [Related]
18. Severe Systemic Envenomation Following Vipera berus Bite Managed with ViperaTAb Antivenom.
Hamilton J; Kause J; Lamb T
Wilderness Environ Med; 2019 Mar; 30(1):56-58. PubMed ID: 30385100
[TBL] [Abstract][Full Text] [Related]
19.
Al-Shekhadat RI; Lopushanskaya KS; Segura Á; Gutiérrez JM; Calvete JJ; Pla D
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30717298
[TBL] [Abstract][Full Text] [Related]
20. Coronary thrombosis after European adder bite in a patient on dual antiplatelet therapy: A case report.
Bernasconi L; Schicchi A; Pirozzolo R; Negrini V; Scaravaggi G; Lonati D; Petrolini VM; Locatelli CA
Toxicon; 2022 Dec; 220():106961. PubMed ID: 36347271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
